Dr Lalchandani Labs Ltd vs Gian Lifecare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Dr Lalchandani Labs Ltd is ₹ 6.96 as of 23 Oct 15:30 . The P/E Ratio of Dr Lalchandani Labs Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Gian Lifecare Ltd changed from 9.8 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Gian Lifecare Ltd changed from ₹ 42.97 crore on March 2022 to ₹ 17.77 crore on March 2025 . This represents a CAGR of -19.81% over 4 years The revenue of Dr Lalchandani Labs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Gian Lifecare Ltd for the Dec '25 is ₹ 1.21 crore as compare to the Sep '25 revenue of ₹ 0.75 crore. This represent the growth of 61.33% The ebitda of Dr Lalchandani Labs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Gian Lifecare Ltd for the Dec '25 is ₹ 0.33 crore as compare to the Sep '25 ebitda of ₹ -0.32 crore. This represent the decline of -203% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Gian Lifecare Ltd changed from ₹ 0.09 crore to ₹ 0.1 crore over 7 quarters. This represents a CAGR of 6.21% The Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Gian Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Gian Lifecare Ltd

Gian Life Care Limited was incorporated as a Public Limited Company and registered with the Registrar of Companies, Uttar Pradesh, Kanpur with the name & style 'Gian Life Care Limited' pursuant to a Certificate of Incorporation dated November 06, 2018.
Subsequently, Company acquired the entire business of M/s Gian Pathology & X-Ray, sole proprietorship concern of its Promoter Mr. Arun Kumar Gupta w.e.f.
March 01, 2019. Company is a fast growing professionally managed organization with an ultra-modem fully integrated, manufacturing facility dedicated to provide diagnostic services.
It established the organization in 2018.
Gian' is committed to Quality services that address the prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. The diagnostic center under the name of 'M/s.

FAQs for the comparison of Dr Lalchandani Labs Ltd and Gian Lifecare Ltd

Which company has a larger market capitalization, Dr Lalchandani Labs Ltd or Gian Lifecare Ltd?

Market cap of Dr Lalchandani Labs Ltd is 6 Cr while Market cap of Gian Lifecare Ltd is 4 Cr

What are the key factors driving the stock performance of Dr Lalchandani Labs Ltd and Gian Lifecare Ltd?

The stock performance of Dr Lalchandani Labs Ltd and Gian Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lalchandani Labs Ltd and Gian Lifecare Ltd?

As of October 25, 2026, the Dr Lalchandani Labs Ltd stock price is INR ₹6.96. On the other hand, Gian Lifecare Ltd stock price is INR ₹4.2.

How do dividend payouts of Dr Lalchandani Labs Ltd and Gian Lifecare Ltd compare?

To compare the dividend payouts of Dr Lalchandani Labs Ltd and Gian Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.